Skip to content
10-Q

Quarterly Report

Lyra Therapeutics, Inc. LYRA

0000950170-25-107367

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 1.64M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.35M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.33M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.31M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.29M sh
Capex Q2 2025 · Jun 30, 2025 $20K
Capex Q2 2025 · Jun 30, 2024 $2.35M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$15.43M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$42.44M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $29.78M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $40.58M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.62M
Stockholders Equity Q2 2025 · Mar 31, 2025 $3.87M
Stockholders Equity Q2 2025 · Dec 31, 2024 $11.59M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 $30.97M
Stockholders Equity Q2 2025 · Mar 31, 2024 $77.5M
Stockholders Equity Q2 2025 · Dec 31, 2023 $89.42M
Current Liabilities Q2 2025 · Jun 30, 2025 $11.16M
Current Liabilities Q2 2025 · Dec 31, 2024 $12.63M
Total Liabilities Q2 2025 · Jun 30, 2025 $50.95M
Total Liabilities Q2 2025 · Dec 31, 2024 $54.75M
Current Assets Q2 2025 · Jun 30, 2025 $31.06M
Current Assets Q2 2025 · Dec 31, 2024 $43.03M
Total Assets Q2 2025 · Jun 30, 2025 $52.57M
Total Assets Q2 2025 · Dec 31, 2024 $66.35M
Eps Diluted Q2 2025 · Jun 30, 2025 −$5.51
Eps Diluted Q2 2025 · Jun 30, 2025 −$12.00
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$36.76
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$54.51
Eps Basic Q2 2025 · Jun 30, 2025 −$5.51
Eps Basic Q2 2025 · Jun 30, 2025 −$12.00
Eps Basic restated Q2 2025 · Jun 30, 2024 −$36.76
Eps Basic restated Q2 2025 · Jun 30, 2024 −$54.51
Sga Expense Q2 2025 · Jun 30, 2025 $3.5M
Sga Expense Q2 2025 · Jun 30, 2025 $6.76M
Sga Expense Q2 2025 · Jun 30, 2024 $5.14M
Sga Expense Q2 2025 · Jun 30, 2024 $10.96M
Rd Expense Q2 2025 · Jun 30, 2025 $5.11M
Rd Expense Q2 2025 · Jun 30, 2025 $9.99M
Rd Expense Q2 2025 · Jun 30, 2024 $13.26M
Rd Expense Q2 2025 · Jun 30, 2024 $31.5M
Net Income Q2 2025 · Jun 30, 2025 −$7.44M
Net Income Q2 2025 · Jun 30, 2025 −$15.98M
Net Income Q2 2025 · Mar 31, 2025 −$8.55M
Net Income Q2 2025 · Jun 30, 2024 −$48.13M
Net Income Q2 2025 · Jun 30, 2024 −$70.58M
Net Income Q2 2025 · Mar 31, 2024 −$22.45M
Operating Income Q2 2025 · Jun 30, 2025 −$8.83M
Operating Income Q2 2025 · Jun 30, 2025 −$17.67M
Operating Income Q2 2025 · Jun 30, 2024 −$48.97M
Operating Income Q2 2025 · Jun 30, 2024 −$72.5M
Revenue Q2 2025 · Jun 30, 2025 $183K
Revenue Q2 2025 · Jun 30, 2025 $366K
Revenue Q2 2025 · Jun 30, 2024 $598K
Revenue Q2 2025 · Jun 30, 2024 $1.13M